Drug companies involved in TrumpRx boosted lobbying by 23% ahead of program’s launch

US President Donald Trump speaks about TrumpRx website as the Administrator for the Centers for Medicare & Medicaid Services Mehmet Oz listens, in the South Court Auditorium of the White House in Washington, DC, on February 5, 2026.

Drug companies involved in TrumpRx boosted lobbying by 23% ahead of program’s launch

Originally published on opensecrets.org, part of the BLOX Digital Content Exchange.

Recommended for you